Patents Assigned to NEXTAGE THERAPEUTICS LTD.
  • Publication number: 20220265555
    Abstract: Described herein are liposomes containing modified targeting peptides. Liposomes preferably comprise a lipid-based bilayer and at least one cannabinoid. Also provided herein are methods for making the liposomes, and methods for treatment of diseases of the CNS using the liposomes.
    Type: Application
    Filed: August 31, 2020
    Publication date: August 25, 2022
    Applicant: NEXTAGE THERAPEUTICS LTD.
    Inventor: Joseph Yeshayahu KLEIN